M Monconduit

599 total citations
20 papers, 429 citations indexed

About

M Monconduit is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, M Monconduit has authored 20 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in M Monconduit's work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). M Monconduit is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). M Monconduit collaborates with scholars based in France, Tunisia and Czechia. M Monconduit's co-authors include Christophe Louvet, N Smadja, Christian Bastard, F Isnard, Nathalie Cheron, Thierry Façon, B. Grosbois, Claire Mathiot, Philippe Moreau and Michel Attal and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and British Journal of Haematology.

In The Last Decade

M Monconduit

19 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Monconduit France 9 313 231 167 65 50 20 429
Philip R. Greipp United States 7 201 0.6× 163 0.7× 117 0.7× 85 1.3× 40 0.8× 8 324
Laurence Detourmignies France 9 237 0.8× 195 0.8× 100 0.6× 70 1.1× 87 1.7× 16 402
JM Hernández Spain 8 346 1.1× 187 0.8× 115 0.7× 100 1.5× 54 1.1× 12 426
RA Kyle United States 9 436 1.4× 309 1.3× 207 1.2× 84 1.3× 20 0.4× 9 503
M Meldrum United Kingdom 8 271 0.9× 152 0.7× 167 1.0× 55 0.8× 84 1.7× 9 371
D Borrego Spain 7 342 1.1× 186 0.8× 155 0.9× 105 1.6× 47 0.9× 11 414
Margherita Girino Italy 8 103 0.3× 115 0.5× 90 0.5× 52 0.8× 31 0.6× 30 338
Hideaki Sakabe Japan 7 173 0.6× 269 1.2× 159 1.0× 54 0.8× 60 1.2× 10 473
Gerald Gehbauer Germany 5 204 0.7× 176 0.8× 102 0.6× 32 0.5× 33 0.7× 5 330
M V Joyner United Kingdom 11 297 0.9× 131 0.6× 145 0.9× 161 2.5× 59 1.2× 24 444

Countries citing papers authored by M Monconduit

Since Specialization
Citations

This map shows the geographic impact of M Monconduit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Monconduit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Monconduit more than expected).

Fields of papers citing papers by M Monconduit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Monconduit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Monconduit. The network helps show where M Monconduit may publish in the future.

Co-authorship network of co-authors of M Monconduit

This figure shows the co-authorship network connecting the top 25 collaborators of M Monconduit. A scholar is included among the top collaborators of M Monconduit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Monconduit. M Monconduit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakoub‐Agha, Ibrahim, Michel Attal, Charles Dumontet, et al.. (2002). Thalidomide in patients with advanced multiple myeloma: a study of 83 patients–report of the intergroupe francophone du myélome (IFM). The Hematology Journal. 3(4). 185–192. 65 indexed citations
2.
Goasguen, J, Marc Zandecki, Claire Mathiot, et al.. (1999). Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leukemia Research. 23(12). 1133–1140. 39 indexed citations
3.
Smadja, N, F Isnard, Christophe Louvet, et al.. (1998). Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. Leukemia. 12(6). 960–969. 133 indexed citations
4.
Moreau, Philippe, D Fière, W. R. Bezwoda, et al.. (1997). Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma.. Journal of Clinical Oncology. 15(2). 660–666. 34 indexed citations
5.
Noordijk, E.M., Patrice Carde, Anton Hagenbeek, et al.. (1997). 77 Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I–II Hodgkin's disease six-year results of the EORTC-GPMC controlled clinical trials ‘H7-VF’, ‘H7-F’ and ‘H7-U’. International Journal of Radiation Oncology*Biology*Physics. 39(2). 173–173. 32 indexed citations
6.
Mejjad, O., Xavier Le Loët, Jean-François Ménard, et al.. (1996). Osteocalcin is not a marker of progress in multiple myeloma. European Journal Of Haematology. 56(1-2). 30–34. 7 indexed citations
7.
Mathiot, Claire, Jean–Yves Mary, Éric Tartour, et al.. (1996). Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). British Journal of Haematology. 95(4). 660–665. 7 indexed citations
8.
Andreu, G., M Benbunan, M Boasson, et al.. (1994). [Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia].. PubMed. 35(6). 517–22. 6 indexed citations
9.
Mathiot, Claire, Jean‐Luc Teillaud, Véronique Mosseri, et al.. (1993). Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma. Journal of Clinical Immunology. 13(1). 41–48. 33 indexed citations
10.
Lévesque, H., J.Y. Borg, N. Cailleux, et al.. (1993). Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.. PubMed. 2(5). 287–8. 25 indexed citations
11.
Vasse, Marc, et al.. (1993). Potent activity of peripheral blood lymphocytes in inducing hepatocyte stimulating factor and urokinase in monocytes. Blood Coagulation & Fibrinolysis. 4(1). 143–147. 4 indexed citations
12.
Monconduit, M. (1992). Les traitements du myélome multiple en 1992. La Revue de Médecine Interne. 13(4). 315–318. 1 indexed citations
13.
Wajcman, Henri, J. Kister, M.C. Marden, et al.. (1992). Homoglobin Rouen (α-140 (HC2) Tyr→His): alteration of the α-chain C-terminal region and moderate increase in oxygen affinity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1180(1). 53–57. 10 indexed citations
14.
Monconduit, M, Jean-François Ménard, J. L. Michaux, et al.. (1992). VAD or VMBCP in severe multiple myeloma. British Journal of Haematology. 80(2). 199–204. 16 indexed citations
15.
Daragon, A, et al.. (1992). [Aspergillus spondylodiscitis. A case].. PubMed. 21(15). 721–2. 2 indexed citations
16.
Deharo, Steve, et al.. (1987). [Spontaneous remission of refractory anemia with excess of blasts after septicemia].. PubMed. 138(8). 663–4. 1 indexed citations
17.
Monconduit, M, et al.. (1987). [Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].. PubMed. 54(6). 477–9. 1 indexed citations
18.
Vannier, J.P., M Monconduit, & H Piguet. (1980). [Comparison between 2 density gradients for separation of CFU].. PubMed. 33(7). 236–9. 6 indexed citations
19.
Monconduit, M, et al.. (1977). Rheumatic symptoms in Crohn's disease and the HLA system.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(1). 41–2. 6 indexed citations
20.
Deshayes, P, Y Geffroy, C Houdent, et al.. (1976). [Rheumatic manifestations in 80 cases of Crohn's disease].. PubMed. 43(5). 345–55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip R. Greipp Breakdown of academic impact, for papers by Laurence Detourmignies Breakdown of academic impact, for papers by JM Hernández Breakdown of academic impact, for papers by RA Kyle Breakdown of academic impact, for papers by M Meldrum Breakdown of academic impact, for papers by D Borrego Breakdown of academic impact, for papers by Margherita Girino Breakdown of academic impact, for papers by Hideaki Sakabe Breakdown of academic impact, for papers by Gerald Gehbauer Breakdown of academic impact, for papers by M V Joyner
Rankless by CCL
2026